Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 1 Radiation Injuries 1 Mixed Tumor, Mesodermal 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Clinical Stage I Gastric Cancer AJCC v8 1 Breast Neoplasms 1

Interventions

Fulvestrant 64 Letrozole 54 Paclitaxel 49 Trastuzumab 41 pembrolizumab 40 ribociclib 37 Specimen Handling 37 palbociclib 36 Capecitabine 34 Anastrozole 34 Carboplatin 33 Tamoxifen 32 exemestane 30 pertuzumab 28 abemaciclib 28 Magnetic Resonance Spectroscopy 26 Cyclophosphamide 26 trastuzumab deruxtecan 24 Surveys and Questionnaires 21 Biopsy 19 Radiotherapy 18 olaparib 17 Blood Specimen Collection 17 Standard of Care 16 Docetaxel 16 Taxes 14 Mastectomy, Segmental 14 eribulin 13 elacestrant 13 Methods 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Lymph Node Excision × 90 days × Clear all

NCT04889924 2026-05-19

ADARNAT

Hospital Universitari de Bellvitge

Phase NA Recruiting

Breast Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon ⚡